Simbolo M, Centonze G, Gkountakos A, Monti V, Maisonneuve P, Golovco S
Virchows Arch. 2024; 484(5):777-788.
PMID: 38168015
PMC: 11106141.
DOI: 10.1007/s00428-023-03721-4.
Liu L, Li C, Wu Z, Li Y, Yu H, Li T
Cancers (Basel). 2023; 15(22).
PMID: 38001705
PMC: 10670470.
DOI: 10.3390/cancers15225445.
Zhou H, Gao P, Liu F, Shi L, Sun L, Zhang W
Heliyon. 2023; 9(5):e15924.
PMID: 37223713
PMC: 10200837.
DOI: 10.1016/j.heliyon.2023.e15924.
Ortega M, Pekarek L, Navarro F, Fraile-Martinez O, Garcia-Montero C, Alvarez-Mon M
J Pers Med. 2023; 13(2).
PMID: 36836402
PMC: 9959016.
DOI: 10.3390/jpm13020167.
Chhouri H, Alexandre D, Grumolato L
Cancers (Basel). 2023; 15(2).
PMID: 36672453
PMC: 9856371.
DOI: 10.3390/cancers15020504.
Effect of Chemotherapy in Stage II-IV Large-Cell Lung Carcinoma and Construction of Its Predictive Nomograms: A SEER Analysis.
Hu G, Liu Y, Li X, Jin M, Liu X, Yu Q
Med Princ Pract. 2023; 32(1):49-60.
PMID: 36652925
PMC: 10267498.
DOI: 10.1159/000529202.
Factors for incidence risk and prognosis of synchronous brain metastases in pulmonary large cell carcinoma patients: a population-based study.
Zheng X, Mu S, Wang L, Tao H, Huang D, Huang Z
BMC Pulm Med. 2023; 23(1):12.
PMID: 36635639
PMC: 9835350.
DOI: 10.1186/s12890-023-02312-y.
The Clinical Characteristics and Treatments for Large Cell Carcinoma Patients Older than 65 Years Old: A Population-Based Study.
Yao A, Liang L, Rao H, Shen Y, Wang C, Xie S
Cancers (Basel). 2022; 14(21).
PMID: 36358648
PMC: 9658669.
DOI: 10.3390/cancers14215231.
Comprehensive Characterization of Human Lung Large Cell Carcinoma Identifies Transcriptomic Signatures with Potential Implications in Response to Immunotherapy.
Ramos-Paradas J, Gomez-Sanchez D, Rosado A, Ucero A, Ferrer I, Garcia-Lujan R
J Clin Med. 2022; 11(6).
PMID: 35329826
PMC: 8953709.
DOI: 10.3390/jcm11061500.
Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma.
Liang Z, Wang W, Hu Q, Zhou P, Zhang Y, Tang Y
Diagn Pathol. 2022; 17(1):26.
PMID: 35144629
PMC: 8832809.
DOI: 10.1186/s13000-022-01204-9.
Current Landscape of Non-Small Cell Lung Cancer: Epidemiology, Histological Classification, Targeted Therapies, and Immunotherapy.
Rodak O, Peris-Diaz M, Olbromski M, Podhorska-Okolow M, Dziegiel P
Cancers (Basel). 2021; 13(18).
PMID: 34572931
PMC: 8470525.
DOI: 10.3390/cancers13184705.
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.
Lindsay C, Shaw E, Moore D, Rassl D, Jamal-Hanjani M, Steele N
Br J Cancer. 2021; 125(9):1210-1216.
PMID: 34489586
PMC: 8548341.
DOI: 10.1038/s41416-021-01407-9.
MicroRNA expression profiling and biomarker validation in treatment-naïve and drug resistant non-small cell lung cancer.
MacDonagh L, Gallagher M, Ffrench B, Gasch C, Gray S, Reidy M
Transl Lung Cancer Res. 2021; 10(4):1773-1791.
PMID: 34012792
PMC: 8107736.
DOI: 10.21037/tlcr-20-959.
Pulmonary large cell carcinoma, highly positive for PD-L1, shows marked response to pembrolizumab: A case report.
Okabe N, Mine H, Takagi H, Watanabe M, Muto S, Matsumura Y
Thorac Cancer. 2021; 12(7):1141-1144.
PMID: 33605014
PMC: 8017242.
DOI: 10.1111/1759-7714.13850.
Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis.
Baine M, Rekhtman N
Transl Lung Cancer Res. 2020; 9(3):860-878.
PMID: 32676352
PMC: 7354156.
DOI: 10.21037/tlcr.2020.02.13.
Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma.
Yang C, Sanchez-Vega F, Chang J, Chatila W, Shoushtari A, Ladanyi M
Mod Pathol. 2020; 33(11):2244-2255.
PMID: 32581366
PMC: 8386291.
DOI: 10.1038/s41379-020-0594-0.
Clinical characteristics and prognosis of pulmonary large cell carcinoma: A population-based retrospective study using SEER data.
Xiaochuan L, Jiangyong Y, Ping Z, Xiaonan W, Lin L
Thorac Cancer. 2020; 11(6):1522-1532.
PMID: 32301286
PMC: 7262949.
DOI: 10.1111/1759-7714.13420.